Garth David Ehrlich
12Patents
4h-index
22Co-inventors
60Inventor score
Filing activity: Oct 14, 1997 → May 14, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6258570A | PCR assay for bacterial and viral meningitis | Chemistry; Metallurgy | 24 | Expired |
| US8425775B2 | Biofilm remediation of fracture fluid | Emerging Cross-Sectional Technologies | 9 | Active |
| US8747883B2 | Medical item for long term drug release | Emerging Cross-Sectional Technologies | 8 | Active |
| US8815562B2 | Biosynthetic pathway for heterologous expression of a nonribosomal peptide synthetase drug and analogs | Chemistry; Metallurgy | 5 | Active |
| US6969762B2 | Selected nucleotide sequences isolated from pathogenic strains of Haemophilus influenzae | Chemistry; Metallurgy | 3 | Expired |
| US9611491B2 | Biosynthetic pathway for heterologous expression of a nonribosomal peptide synthetase drug and analogs | Chemistry; Metallurgy | 1 | Active |
| US8480902B2 | Biofilm remediation of acid mine drainage | Emerging Cross-Sectional Technologies | 0 | Active |
| US8425776B2 | Biofilm remediation of metal containing wastewater | Emerging Cross-Sectional Technologies | 0 | Active |
| US11666555B2 | RelA inhibitors for biofilm disruption | Emerging Cross-Sectional Technologies | 0 | Active |
| US6406846B1 | Method for determining whether a human patient is susceptible to hereditary pancreatitis, and primers therefore | Chemistry; Metallurgy | 0 | Expired |
| US7268225B2 | Selected nucleotide sequences isolated from pathogenic strains of Haemophilus influenzae | Chemistry; Metallurgy | 0 | Active |
| US7115732B2 | Selected nucleotide sequences isolated from pathogenic strains of Haemophilus influenzae | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.